Table 3

HIV incidence among young women who sell sex testing HIV negative at enrolment, by arm (A) and site (B) (N=1017)

Number of seroconversions/person-years of follow-upRate per 100 person-years (95% CI)Age-adjusted rate ratio (95% CI) p valueFully adjusted rate ratio (95% CI)* p value
(A) Comparison of HIV incidence among YWSS testing HIV negative at enrolment, by arm
Non-DREAMS (N=479)48/907.625.29 (3.99 to 7.02)1.01.0
DREAMS (N=538)31/988.143.14 (2.21 to 4.46)0.59 (0.38 to 0.93) p=0.0220.68 (0.40 to 1.19) p=0.176
(B) Comparison of HIV incidence among YWSS testing HIV negative at enrolment, by site
DREAMS Site A (n=252)16/444.743.60 (2.20 to 5.87)1.0
DREAMS Site B (n=286)15/543.402.76 (1.66 to 4.58)0.75 (0.37 to 1.52) p=0.4200.68 (0.33 to 1.43) p=0.313
Non-DREAMS Site C (n=121)16/226.247.07 (4.33 to 11.54)1.93 (0.96 to 3.88) p=0.0631.56 (0.74 to 3.29) p=0.243
Non-DREAMS Site D (n=102)11/192.905.70 (3.16 to 10.30)1.57 (0.73 to 3.38) p=0.2521.33 (0.58 to 3.03) p=0.503
Non-DREAMS Site E (n=141)12/278.414.31 (2.45 to 7.59)1.21 (0.57 to 2.56) p=0.6171.04 (0.46 to 2.38) p=0.923
Non-DREAMS Site F (n=115)9/210.074.28 (2.23 to 8.23)1.16 (0.51 to 2.63) p=0.7231.00 (0.43 to 2.34) p=0.996
  • *Adjusted for age, highest level of education attained, marital status, self-identification as female sex workers, STI symptoms, number of sexual partners in the past month, HIV prevalence (measured at enrolment).

  • DREAMS, Determined, Resilient, Empowered, AIDS-free, Mentored and Safe; STI, sexually transmitted infection; YWSS, young women who sell sex.